The Centers for Medicare & Medicaid Services (CMS) is poised to usher in a new era of healthcare administration with the upcoming launch of the Wasteful and Inappropriate Service Reduction (WISeR) Model. This groundbreaking pilot program, set to begin on January 1, 2026, will integrate artificial intelligence (AI) into the prior
A number of stocks fell in the afternoon session after the U.S. Commerce Department initiated a national security investigation into medical equipment and devices, raising concerns about potential tariffs.
The healthcare sector finds itself in turbulent waters in 2025, registering a concerning 5% slump and significantly lagging the overall S&P 500 index. This downturn marks a continuation of a multi-year trend of muted returns for a sector traditionally viewed as defensive and resilient. The underperformance is not merely
The healthcare payer industry is reeling following a challenging second quarter, epitomized by UnitedHealth Group's (NYSE: UNH) significant earnings miss and the deepening shadow of a federal Medicare fraud investigation. These developments are not isolated incidents but rather stark indicators of mounting pressures within the health insurance sector, characterized by
The healthcare sector is currently experiencing a period of profound transformation, marked by a fascinating dichotomy: groundbreaking medical innovations are driving unprecedented growth for some, while intense regulatory scrutiny and escalating costs pose significant challenges for others. This intricate interplay between scientific advancement and a complex operating environment is reshaping
UnitedHealth Group (NYSE: UNH), a titan in the U.S. healthcare industry, is grappling with a formidable array of financial and operational challenges that are poised to exert immediate and substantial downward pressure on its Q3 2025 Earnings Per Share (EPS) estimates. A confluence of escalating high-acuity care costs, unfavorable
UnitedHealth Group (NYSE: UNH), a dominant force in the U.S. healthcare landscape, is currently embroiled in an unprecedented storm of regulatory and legal scrutiny. Federal Justice Department probes targeting its expansive vertical integration and Medicare Advantage billing practices are intensifying, while the company continues to reel from the catastrophic
Wall Street kept driving equity valuations higher on Friday, extending the momentum from Thursday when all major U.S. benchmarks closed at record highs following the Federal Reserve's rate cut.
Looking for the S&P500 stocks that are experiencing notable gaps on Friday? Find out which stocks are gapping up and gapping down in the S&P500 index during today's session.
Stay tuned for the market movements in the S&P500 index on Tuesday. Check out the gap up and gap down stocks in the S&P500 index during today's session.
Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence.
With such vast footprints, however, finding new areas for growth is much harder than for smaller, more agile players.
Earnings misses, weak guidance, and downgrades drove large-cap decliners—led by Synopsys, Chewy, and The Trade Desk—while biotech trial updates and mixed analyst calls pressured others.
Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Wednesday. Discover the gap up and gap down stocks in the S&P500 index.
Before the US market kicks off on Wednesday, let's examine the pre-market session and unveil the notable performers among the S&P500 top gainers and losers.
Shares of health insurance company Humana (NYSE:HUM)
jumped 1.8% in the afternoon session after Bank of America Securities raised its price target for the company. The firm maintained its "Neutral" rating on Humana but increased its price target to $312 from $285, representing a potential 9.5% upside from the previous target. This analyst action follows other recent positive developments for the healthcare company. In late August, Humana announced new value-based care partnerships with Vori Health and HOPCo. These partnerships are aimed at expanding individualized musculoskeletal care for its Medicare Advantage members, signaling continued efforts to enhance its service offerings.
